Business Context and Reporting Period
This Form 8-K reports on events occurring on February 11, 2019, for Monocle Acquisition Corporation (a Delaware corporation and emerging growth company). The filing details the completion of the Company's Initial Public Offering (IPO) and a concurrent private placement. Note: The request metadata references "Aersale Corp," but the filing text explicitly identifies the registrant as Monocle Acquisition Corporation.
Key Financial Metrics
- IPO Gross Proceeds: $172,500,000 from the sale of 17,250,000 Units (including 2,250,000 Units from the full exercise of the underwriters' over-allotment option) at $10.00 per Unit.
- Private Placement Proceeds: $7,175,000 from the sale of 717,500 Private Units at $10.00 per Unit.
- Total Gross Proceeds: $179,675,000.
- Trust Account Deposit: $174,225,000 of net proceeds were deposited into a trust account for public stockholders.
- Warrant Terms: Each Unit includes one redeemable warrant exercisable to purchase one share of Common Stock at $11.50 per share.
- Debt and Liquidity: The filing text does not provide specific values for outstanding debt, operating cash flow, or profit margins, as this is a capital formation event for a special purpose acquisition company (SPAC).
Material Changes
The primary material change is the transition from a private entity to a publicly traded company via the IPO. The Company's capital structure now includes 17,250,000 shares of Common Stock and associated warrants held by public investors, alongside shares held by private placement investors. The filing does not provide prior period financial data for comparison as the Company was not previously public.
Guidance, Outlook, and Risks
Management Commentary: The Company has completed its IPO and private placement as planned. An audited balance sheet as of February 11, 2019, reflecting these proceeds, is attached as Exhibit 99.1.
Risks and Contingencies: The filing does not explicitly list risk factors or contingencies in this specific excerpt, though the structure implies standard SPAC risks related to the trust account and the requirement to consummate a business combination.
Unusual Items: None reported in this excerpt.
Investor Verification Checklist
- Verify the audited balance sheet attached as Exhibit 99.1 to confirm the exact cash position and working capital after transaction costs.
- Confirm the terms of the trust account, including interest rate assumptions and withdrawal restrictions.
- Review the underwriting agreement to understand the full extent of the over-allotment option exercise.
- Check the Company's Form S-1 (File No. 333-228470) for detailed risk factors and the timeline for completing a business combination.